Stockreport

Novartis (SWX:NOVN) Valuation After Key Ianalumab Phase III Success and Expanded Itvisma FDA Approval [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Novartis (SWX:NOVN) is back on many investors radar after two clear clinical wins: a broader US FDA approval for Itvisma in spinal muscular atrophy and strong Phase III [Read more]